- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow SCHERING-PLOUGH RESEARCH INSTITUTE Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 242152 [Title] => CAIs: Reaching optimal cholesterol goals [Summary] => A new class of lipid-lowering therapy could make it easier for patients with high cholesterol levels to reach their optimal cholesterol goals.
Such was the good news relayed by Dr. Werner Katzmann, Ph.D., Far East regional medical director of the Schering-Plough Research Institute, in a lecture during the joint annual convention of the Philippine Society of Hypertension and Philippine Lipid Society recently.
[DatePublished] => 2004-03-11 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 239583 [Title] => Lowering LDL-C gets a boost with breakthrough drug [Summary] => A new drug that will reinforce physicians existing therapeutic tools in lowering a patients low-density lipoprotein (LDL-C) or the bad cholesterol, is now out in the market.
Ezetimibe, launched by Schering-Plough Phils. Inc., has been shown to have a clinically significant supplementary effect when used with a statin, reducing LDL-C by an additional 25 percent.
[DatePublished] => 2004-02-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
SCHERING-PLOUGH RESEARCH INSTITUTE
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 242152 [Title] => CAIs: Reaching optimal cholesterol goals [Summary] => A new class of lipid-lowering therapy could make it easier for patients with high cholesterol levels to reach their optimal cholesterol goals.
Such was the good news relayed by Dr. Werner Katzmann, Ph.D., Far East regional medical director of the Schering-Plough Research Institute, in a lecture during the joint annual convention of the Philippine Society of Hypertension and Philippine Lipid Society recently.
[DatePublished] => 2004-03-11 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 239583 [Title] => Lowering LDL-C gets a boost with breakthrough drug [Summary] => A new drug that will reinforce physicians existing therapeutic tools in lowering a patients low-density lipoprotein (LDL-C) or the bad cholesterol, is now out in the market.
Ezetimibe, launched by Schering-Plough Phils. Inc., has been shown to have a clinically significant supplementary effect when used with a statin, reducing LDL-C by an additional 25 percent.
[DatePublished] => 2004-02-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
March 11, 2004 - 12:00am
February 19, 2004 - 12:00am
Recommended
The Insurance Commission has placed health maintenance organization Stotsenberg Healthcare Systems Inc.under conservatorship amid its inability to address requirements from the government.
1 day ago
Lotto Sep 19, 2024
EZ2 - 12 21
SUERTRES - 2 1 3
6D Lotto - 7 5 9 3 0 1
6/42 Lotto - 5 26 2 21 8 27
P19,033,913.00
6/49 Super Lotto - 32n 24 38 35 15
P62,95,035.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66